Baseline sarcopenia and subsequent dementia after incident atrial fibrillation or flutter in the UK Biobank - 19/11/26
Abstract |
Background |
The association between sarcopenia and dementia after incident atrial fibrillation or flutter (AF/flutter) remains uncertain.
Methods |
We studied 30,743 UK Biobank participants free of AF/flutter at recruitment who subsequently had a first recorded AF/flutter event. Sarcopenia was assessed at recruitment; dementia follow-up began at that event. Analyses used Cox and Fine–Gray models, propensity-score matching and restricted cubic splines. Exploratory analyses tested interactions with AF/flutter, heart failure and coronary artery disease status at entry.
Results |
Sarcopenia was present in 2,279 participants (7.4%). Over a median 4.27 years after AF/flutter entry, 1,155 developed dementia. Recruitment preceded entry by a median 8.50 years. Fully adjusted analyses included 26,430 participants and 998 all-cause dementia events. Sarcopenia was associated with all-cause dementia in Cox (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.16–1.72) and Fine–Gray models (subdistribution HR, 1.31; 95% CI, 1.08–1.59). The matched Cox HR was 1.35 (95% CI, 1.09–1.66). Fully adjusted Cox HRs were 1.64 (95% CI, 1.15–2.35) for vascular dementia and 1.34 (95% CI, 0.92–1.93) for Alzheimer’s disease. No interactions with cardiovascular condition status were detected.
Conclusions |
Sarcopenia assessed at recruitment was associated with all-cause dementia after incident AF/flutter. Prospective studies should assess the clinical value of muscle measurements near AF/flutter diagnosis.
Le texte complet de cet article est disponible en PDF.Keywords : Atrial fibrillation, Atrial flutter, Dementia, Sarcopenia, Handgrip strength, UK biobank
Plan
Vol 31 - N° 2
Article 101036- février 2027 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

